Hook & thesis
Kaspi.kz is the dominant digital ecosystem in Kazakhstan: payments, marketplace and fintech all converged in a single super app. At a current price of $98.89 the market is pricing the company conservatively - the shares trade at a roughly $18.98 billion market capitalization with a trailing P/E around 8.9 and a dividend yield north of 3.5%. For an asset that generates high-frequency engagement, sticky deposits and recurring lending flows, that multiple looks cheap.
My call is straightforward: buy KSPI on dips with a long-term horizon (180 trading days). The combination of resilient Kazakhstan core performance, recurring dividend distribution, and the potential for accretive M&A or international expansion to lift earnings argues for upside to my $115 target. That said, the path is not risk free; Turkey expansion, governance questions, and regulatory or sanctions overhangs are the primary debits to the thesis and need active monitoring.
What Kaspi.kz does and why it matters
Kaspi.kz operates three integrated platforms: a Payments Platform for consumers and merchants, a Marketplace Platform connecting buyers and sellers, and a Fintech Platform that hosts deposits, consumer finance and personal finance tools via the Kaspi super app. The company’s closed-loop model turns payments into data, data into credit and product recommendations, and credit into more transactions and deposits. That circularity is why Kaspi has durable unit economics in a market with limited local competition.
Investors should care because Kaspi is not just a payments processor or a bank; it is a high-frequency consumer touchpoint embedded in everyday spending. That creates recurring revenue streams from payments and merchant services, as well as higher-margin financing and deposit income from the fintech side. The business is asset-light from a retail footprint perspective while being capital-efficient in monetizing customer relationships.
Hard numbers that support the case
- Current price: $98.885. 52-week range: low $68.59, high $109.94.
- Market capitalization: approximately $18.98 billion.
- Valuation metrics: P/E ~8.93, P/B ~3.40.
- Dividend and yield: dividend per share $2.144385 and a dividend yield around 3.56%; an Extraordinary General Meeting on 06/11/2026 approved an 850 KZT per share dividend for Q1 2026.
- Liquidity and float: float roughly 153.9 million shares; shares outstanding about 191.95 million; average volume ~773,582 shares (30-day average ~701,495).
- Capital markets activity: the company issued a $650 million Eurobond with a 6.25% coupon due 2030 to support general corporate purposes, improving its access to dollar funding.
Market and sentiment snapshot
Technically, the stock is in a mixed-to-neutral posture: the 10- and 20-day SMAs sit above current levels (SMA10 $102.45, SMA20 $103.93), while the 50-day SMA is lower at $96.06, suggesting the stock is in a recovery phase after a mid-year pullback. RSI near 46 indicates no overbought or deeply oversold condition. MACD shows bearish momentum in the short run, so timing matters when entering a position.
Short interest has been meaningful but trending down from peaks earlier in the year. The most recent short interest prints show coverage days generally under five days, and daily short volume readings indicate active trading interest. That dynamic increases intraday volatility but can also create positive squeezes if fundamentals accelerate.
Valuation framing
At ~8.9x earnings and a market cap near $19.0B, Kaspi trades like a mature, slower-growth financial with better-than-average margins. That is defensible if management misallocates capital abroad or regulatory shocks materialize. But if the Kazakhstan core holds and deposit + credit margins remain intact, a re-rating toward a mid-teens P/E is reasonable over a 6-12 month horizon as earnings convert into visible cash returns to shareholders via regular dividends and optional capital returns.
Put differently: the market is pricing a significant execution discount. That discount is partly explained by credible concerns - international expansion plans and governance questions have created uncertainty. The valuation therefore contains an implicit risk premium that can compress if management demonstrates discipline or if Turkey integration proves accretive rather than dilutive.
Catalysts
- Execution and integration of the Rabobank Turkey acquisition - the share purchase agreement was announced on 11/28/2025 and completion pending regulatory approvals could materially increase scale and cross-sell opportunities if done accretively.
- Regular dividend distributions and potential special distributions - shareholder-friendly payouts (including the 850 KZT Q1 2026 payment approved 06/11/2026) will keep income investors engaged.
- Visibility from quarterly results showing stable payment volumes and loan book quality - consistent KPIs will reduce the valuation discount.
- Any successful deleveraging or prudent capital allocation that demonstrates management discipline after international moves; the company’s $650 million Eurobond (03/21/2025) shows access to funding that could support disciplined growth.
Trade plan (actionable)
Entry price: $98.50. Target price: $115.00. Stop loss: $90.00. Suggested direction: long. Time horizon: long term (180 trading days).
Rationale: Entering around $98.50 puts you below today’s quote and within a reasonable range of short-term technical support near the 50-day SMA ($97.39) while keeping downside controlled. The $115 target is achievable if the market grants a modest re-rating toward a mid-teens P/E and modest earnings growth or improved payout visibility. The $90 stop limits downside to clearly signaled deterioration below the recent trading band and protects against outsized geopolitical or regulatory shocks.
Suggested position sizing: keep allocation size sensible relative to portfolio volatility and idiosyncratic risks (governance/regulatory) - for most retail accounts that means no more than 3-5% of portfolio capital on an initial position, with the option to scale up on confirmed positive catalysts.
Counters to my thesis
There are plausible paths that erase shareholder value. If Turkey expansion consumes capital and produces lower margins or higher credit losses than expected, the acquisition could be dilutive. Governance or accounting concerns and any renewed investigations could push investors to demand a larger discount. Finally, sanctions or geopolitical shifts that constrain business with key counterparties would materially harm revenue visibility and access to capital.
Risks
- Regulatory and geopolitical risk: operating in Kazakhstan and expanding into Turkey exposes the company to regulatory changes, sanctions risk, and political volatility that could affect operations or profitability.
- Execution risk on international expansion: the Rabobank Turkey deal needs regulatory clearances and integration discipline; poor execution could destroy value.
- Governance and litigation overhang: class action suits and questions about related-party transactions have been raised in the past and can keep a valuation cap on the stock until resolved.
- Macroeconomic and currency exposure: loan performance and deposit behavior are sensitive to local economic cycles and KZT/USD movements, which can compress net interest margins.
- Short-term technical risk: bearish MACD and short-interest-driven volatility can generate sharp pullbacks unrelated to fundamentals; keep stops strict.
What would change my mind
I would reassess the bullish stance if any of the following happens: 1) a material deterioration in loan book quality or a surprise rise in NPLs; 2) clear evidence that Turkey operations are dilutive to earnings per share over a 12-month horizon; 3) a new credible regulatory sanction or enforcement action; or 4) management abandons shareholder returns in favor of value-destructive, unrelated diversification.
Conclusion
Kaspi.kz is a high-quality, vertically integrated fintech and marketplace with durable network effects, recurring cash flows, and an attractive dividend. The stock is not without risks - Turkey expansion, governance questions and regulatory uncertainty justify some of the market’s caution. But with a current market cap near $19.0B, a sub-9x P/E, and a 3.6% yield, the risk-reward favors a long position for disciplined investors ready to watch the key catalysts. My trade: buy near $98.50, target $115 over the next 180 trading days, and protect capital with a $90 stop.